Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Behandlingsstederne ATRIUMHUS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.0% 0.7% 0.7% 0.7% 4.6% 2.3% 11.0% 11.0%   Credit score (0-100)   88 95 93 93 45 64 22 22   Credit rating   A AA AA AA BBB BBB BB BB   Credit limit (kDKK)   286.0 710.6 1,032.3 968.6 0.0 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 12,150 0 0 0 0   Gross profit   8,260 9,592 11,427 11,325 8,995 11,376 0.0 0.0   EBITDA   642 1,590 2,913 1,527 -1,657 -171 0.0 0.0   EBIT   321 1,284 2,556 1,103 -2,034 -522 0.0 0.0   Pre-tax profit (PTP)   295.0 1,253.6 2,459.8 1,009.5 -2,104.1 -620.0 0.0 0.0   Net earnings   229.2 976.4 1,891.6 787.8 -1,640.6 -483.1 0.0 0.0   Pre-tax profit without non-rec. items   295 1,254 2,460 1,010 -2,104 -620 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,749 3,444 5,972 6,121 5,772 5,357 0.0 0.0   Shareholders equity total   3,166 4,072 5,853 6,528 4,773 4,290 4,210 4,210   Interest-bearing liabilities   1,094 1,089 1,994 1,816 1,687 1,577 0.0 0.0   Balance sheet total (assets)   7,265 7,821 11,612 10,245 7,848 7,852 4,210 4,210   Net Debt   269 -1,380 -2,685 -1,336 1,040 814 -4,210 -4,210     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 12,150 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Gross profit   8,260 9,592 11,427 11,325 8,995 11,376 0.0 0.0   Gross profit growth   3.5% 16.1% 19.1% -0.9% -20.6% 26.5% -100.0% 0.0%   Employees   14 14 17 19 19 20 0 0   Employee growth %   7.7% 0.0% 21.4% 11.8% 0.0% 5.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,265 7,821 11,612 10,245 7,848 7,852 4,210 4,210   Balance sheet change%   0.0% 7.6% 48.5% -11.8% -23.4% 0.0% -46.4% 0.0%   Added value   642.1 1,589.6 2,913.0 1,526.8 -1,610.4 -171.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 12.6% 0.0% 0.0% 0.0% 0.0%   Investments   -510 -611 2,172 -275 -725 -766 -5,357 0   Net sales trend   0.0 0.0 0.0 0.0 -1.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 12.6% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 9.1% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.9% 13.4% 22.4% 9.7% -22.6% -4.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 6.5% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 10.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 8.3% 0.0% 0.0% 0.0% 0.0%   ROA %   4.4% 17.0% 26.3% 10.1% -22.5% -6.6% 0.0% 0.0%   ROI %   7.2% 25.8% 36.5% 13.0% -27.2% -8.5% 0.0% 0.0%   ROE %   7.4% 27.0% 38.1% 12.7% -29.0% -10.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   60.5% 52.1% 50.4% 63.7% 60.8% 54.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 29.1% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 3.2% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   41.8% -86.8% -92.2% -87.5% -62.7% -474.9% 0.0% 0.0%   Gearing %   34.5% 26.8% 34.1% 27.8% 35.3% 36.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.2% 2.8% 6.3% 4.9% 4.0% 6.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.6 1.7 1.6 2.1 1.2 1.0 0.0 0.0   Current Ratio   1.1 1.7 1.6 2.1 1.2 1.1 0.0 0.0   Cash and cash equivalent   825.2 2,469.1 4,679.0 3,151.9 646.5 762.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 63.3 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 31.7% 0.0% 0.0% 0.0% 0.0%   Net working capital   316.5 1,684.6 2,062.2 1,990.5 275.6 115.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 16.4% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 639 0 0 0 0   Added value / employee   46 114 171 80 -85 -9 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   46 114 171 80 -87 -9 0 0   EBIT / employee   23 92 150 58 -107 -26 0 0   Net earnings / employee   16 70 111 41 -86 -24 0 0